World Journal of Surgery

, Volume 20, Issue 5, pp 593–597 | Cite as

Thyroid Gland Surgery in an Endemic Region

  • Christian A. Seiler
  • Christine Glaser
  • Hans E. Wagner
Original Scientific Reports

Abstract

To assess the incidence, indications, and complications of (reoperative) thyroid gland surgery in an endemic region, we have retrospectively analyzed 1318 patients operated on between 1983 and 1994. There were 166 reoperations (13.5%). In comparison to the primary operation the indication for reoperation showed an increased rate of premalignant and malignant tumors (+16%) and a decreased rate of hyperthyroid disorders (−30%). The largest group operated on had benign multinodular goiters, with the same rate of indication for primary (57.4%) and secondary (57.8%) surgery. Permanent recurrent laryngeal nerve palsy rate following primary operation occurred at rates of 1.7% (1983–1990) and 0.7% (1991–1994) and for secondary operation 3.5% (1983–1990) and 5.6% (1991–1994), respectively. The change in recurrent nerve palsy rate in the later years was due to a more extensive resection policy at the primary operation and a more liberal approach to reoperative surgery. The high rate of reoperation for benign goiters (13%) and the new data of goitrogenesis have therefore directed our policy to more extensive resection of the thyroid tissue at the initial operation, increasing the rate of lobectomy from 27% (1982–1990) to > 90% (1991–1994) and at the same time lowering morbidity. Extensive resection of nodular tissue during the initial operation safely reduces the incidence of recurrent goiter and subsequently reduces the rate of reoperation and eliminates the high risk of morbidity associated with reoperative thyroid surgery. The indications for reoperation should be strict, and when unavoidable a modified lateral approach may be helpful.

Preview

Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.

References

  1. 1.
    Bornhauser, S.: Zur Geschichte der Schilddrüsen- und Kropfforschung im 19: Jahrhundert (unter besonderer Berücksichtigung der Schweiz). Aarau, Sauerländer, 1951Google Scholar
  2. 2.
    Tröhler, U.: Der Nobelpreisträger Theodor Kocher 1841–1917. Basel, Birkhäuser, 1984Google Scholar
  3. 3.
    Welbourn, R.B.: The History of Endocrine Surgery. New York, Praeger, 1990, pp. 1–82Google Scholar
  4. 4.
    Boschung, U.: Theodor Kocher, 1841–1917. Bern, Verlag Hans Huber, 1991Google Scholar
  5. 5.
    Dralle, H., Pichlmayr, R.: Risikominderung bei Rezidiveingriffen wegen benigner Struma. Chirurg 62:169, 1991PubMedGoogle Scholar
  6. 6.
    Levin, K.E., Clark, A.H., Duh, Q-Y., Demeure, M., Siperstein, A.E., Clark, O.H.: Reoperative thyroid surgery. Surgery 111:604, 1992PubMedGoogle Scholar
  7. 7.
    Aeschimann, S., Kopp, P.A., Kimura, E.T., et al.: Morphological and functional polymorphism within clonal thyroid nodules. J. Clin. Endocrinol. Metab. 77:846, 1993PubMedGoogle Scholar
  8. 8.
    Studer, H., Gerber, H., Zbaeren, J., Peter, H-J.: Histomorphological and immunohistochemical evidence that human nodular goiters grow by episodic replication of multiple clusters of thyroid follicular cells. J. Clin. Endocrinol. Metab. 75:1151, 1992PubMedGoogle Scholar
  9. 9.
    Reeve, T.S., Delbridge, L., Cohen, A., Crummer, P.: Total thyroidectomy: the preferred option for multinodular goiter. Ann. Surg. 206:782, 1987PubMedCrossRefGoogle Scholar
  10. 10.
    Jatzko, G.R., Lisborg, P.H., Müller, M.G., Wette, V.M.: Recurrent nerve palsy after thyroid operations: principal nerve identification and a literature review. Surgery 115:139, 1994PubMedGoogle Scholar
  11. 11.
    Lennquist, S.: Surgical strategy in thyroid carcinoma: a clinical review. Acta Chir. Scand. 152:321, 1986PubMedGoogle Scholar
  12. 12.
    Teuscher, J., Peter, H-J., Gerber, H., Berchtold, R., Studer, H.: Pathogenesis of nodular goiter and its implications for surgical management. Surgery 103:87, 1988PubMedGoogle Scholar
  13. 13.
    Westermark, K., Persson, C.P., Johansson, H., Karlsson, F.A.: Nodular goiter: effects of surgery and thyroxine medication. World J. Surg. 10:481, 1986PubMedCrossRefGoogle Scholar
  14. 14.
    Pickardt, C.R., Scriba, P.C.: Was erwartet der Internist vom Chirurgen bei Operation gutartiger Schilddrüsenerkrankungen? Chirurg 62:157, 1991Google Scholar
  15. 15.
    Studer, H., Peter, H-J., Gerber, H.: Natural heterogeneity of thyroid cells: the basis for understanding thyroid function and nodular goiter growth. Endocr. Rev. 10:125, 1989PubMedCrossRefGoogle Scholar
  16. 16.
    Gemsenjäger, E.: Zur Operationstechnik bei Eingriffen an der Schilddrüse. Chirurg 64:725, 1993PubMedGoogle Scholar
  17. 17.
    Seiler, C., Wagner, H.E.: Der Nervus laryngeus inferior non-recurrens: eine wichtige Rarität in der Schilddrüsenchirurgie. Chirurg 65:358, 1994PubMedGoogle Scholar
  18. 18.
    Seiler, C.A., Wagner, H.E.: Recovery from bilateral vocal cord paralysis following thyroid surgery. Br. J. Surg. 81:1760, 1994PubMedCrossRefGoogle Scholar
  19. 19.
    Wagner, H.E., Seiler, C.: Recurrent laryngeal nerve palsy in thyroid gland surgery. Br. J. Surg. 81:226, 1994PubMedCrossRefGoogle Scholar
  20. 20.
    Wagner, H.E., Ballmer, F., Teuscher, J.: Knotenstruma: Thyreoglobulin als Indikator für Rezidivneigung? Helv. Chir. Acta 54:361, 1987PubMedGoogle Scholar
  21. 21.
    Wagner, H.E., Birrer, A., Lüscher, B., Kinser, J., Rösler, H.: Risikofaktoren beim papillären Schilddrüsenkarzinom. Helv. Chir. Acta 59:819, 1992 ReferencesGoogle Scholar

References

  1. 1.
    Nygaard, B., Gideon, P., Dige-Petersen, H., Jespersen, N., Sølling, K., Veje, A.: Thyroid volume and morphology and urinary iodine excretion in a Danish municipality. Acta Endocrinol. (Copenh.) 129:505, 1993Google Scholar
  2. 2.
    Al-Suliman, N.N., Ryttov, N.F., Qvist, N., Blichert-Toft, M., Graversen, H.P.: Experience with thyroid surgery in a specialist unit: a demographic study, surgical complications, and sequelae. Eur. J. Surg. (in press)Google Scholar
  3. 3.
    Cheung, P.S.Y., Lee, J.M.H., Boey, J.H.: Thyroxine suppressive therapy of benign solitary nodules: a prospective randomized study. World J. Surg. 13:818, 1989PubMedCrossRefGoogle Scholar
  4. 4.
    Persson, C.P.A., Johansson, H., Westermark, K., Karlsson, F.A.: Nodular goiter-is thyroxine medication of any value? World J. Surg. 6:391, 1982PubMedCrossRefGoogle Scholar
  5. 5.
    Perrild, H., Hansen, J.M., Hegedüs, L., et al.: Triiodothyronine and thyroxine treatment of diffuse nontoxic goitre evaluated by ultrasonic scanning. Acta Endocrinol. (Copenh.) 100:382, 1982Google Scholar
  6. 6.
    Nygaard, B., Hegedüs, L., Gervil, M., Hjalgrim, H., Søe-Jensen, P., Hansen, J.M.: Radioiodine treatment of multinodular nontoxic goitre. B.M.J. 307:828, 1993CrossRefGoogle Scholar
  7. 7.
    Hegedüs, L., Hansen, J.M., Veiergang, D., Karstrup, S.: Does prophylactic thyroxine treatment after operation for nontoxic goitre influence thyroid size? B.M.J. 294:801, 1987CrossRefGoogle Scholar
  8. 8.
    Bistrup, C., Nielsen, J.D., Gregersen, G., Franch, P.: Preventive effect of levothyroxine in patients operated for nontoxic goitre: a randomized trial of one hundred patients with nine years follow-up. Clin. Endocrinol. (Oxf.) 40:323, 1994CrossRefGoogle Scholar
  9. 9.
    Miccoli, P., Antonelli, A., Iacconi, P., Alberti, B., Sambussa, C., Baschieri, L.: Prospective, randomized, double-blind study about effectiveness of levothyroxine suppressive therapy in prevention of recurrence after operation: result at the third year of follow-up. Surgery 114:1097, 1993PubMedGoogle Scholar

Copyright information

© Société Internationale de Chirugie 1996

Authors and Affiliations

  • Christian A. Seiler
    • 1
  • Christine Glaser
    • 1
  • Hans E. Wagner
    • 1
  1. 1.Department of Visceral and Transplantation SurgeryUniversity of Bern, InselspitalBernSwitzerland

Personalised recommendations